9 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
points: Active bleeding ... #Management #VTE ... #DVT #Algorithm ... Thromboembolism #Treatment #Hematology ... #Anticoagulation
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Superficial - Active Bleeding ... Superficial #Deep #VTE ... #DVT #Hematology ... Management #Anatomy #Anticoagulation ... #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... without concomitant DVT ... #Anticoagulation ... #Management #Hematology ... #Oncology
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... ) and IMPROVE (VTE ... validated for VTE ... #Factors #Hematology ... #Diagnosis
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... DVT = deep vein ... #Anticoagulation ... #Management #Hematology ... #Oncology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management Algorithm ... #Anticoagulation ... #Extension #VTE ... #DVT #Hematology ... #Management #Diagnosis
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Isolated distal DVT ... Unprovoked proximal DVT ... therapy - Second VTE ... #management #hematology ... #anticoagulation
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... • <3mo since VTE ... stratification #diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... • Treatment algorithms ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #hematology